Abstract:Abstract Establishment of a Breast Cancer Rat Model of Chemotherapy-Induced Cardiotoxicity Katherine Wallis, Marjan Boerma, Antiño Allen, Joseph Su, Sam Makhoul, Ping-Ching Hsu Background. Doxorubicin (DOX) is a highly effective chemotherapy agent that is commonly used in combination with precision medicine to treat a wide range of cancers, including 32% of breast cancer (BC) cases. Although the treatment has greatly increased the number of long-term cancer survivors, it has also increased the number of patients experiencing DOX-induced cardiotoxicity (DIC). Animal models have played a vital role in the development of basic and translational breast cancer research in humans, and rat is a preferred animal to study breast cancer for the similarity to human neoplasms and metabolism. However, most studies were established using mouse models, male rats and commonly non-cancer bearing animals. Currently no single universal cancer-bearing female rat model is utilized for DOX-induced chronic cardiotoxicity. The number of cancer cells to be injected to mimic human experience is not known. Large numbers of injected cancer cells grow quickly and kill the animal before the investigators have the time to assess for cardiac toxicity. Here we aimed to identify the minimal number of cancer cell injections to mimic tumor growth of BC patients and to achieve chemotherapy-induced toxicities. Methods. Various numbers (5 × 104 – 1 × 106) of MAT B III adenocarcinoma cancer cells derived from Fischer 344 (F344) rats were injected in the mammary fat pad of female F344 rats, followed by six intraperitoneal (IP) injections of either DOX (1.25mg/kg per dose) or saline post tumor cell injection. The treatments were administered on day 4 from cell injection, and every third day after for a total of six injections. Echocardiography (Vevo 3100, VisualSonics) was conducted before and after the end of chemotherapy. Results. Tumor burden reduced significantly among rats treated with DOX compared with the saline group. In the Kaplan-Meier survival curve, an injection of 5 × 104 cancer cells was associated with tumor growth but the tumor burden was low enough to allow long-term follow-up of both DOX and saline treated rats and assess signs of cardiotoxicity. At 4 days after the final DOX administration, increased left ventricular ejection fraction and fractional shortening in the absence of increased stroke volume were an indication of adverse cardiac effects in the DOX animals but not the saline-treated rats. Plasma was collected from the animals to be subjected to metabolomics testing so that a preliminary assessment of metabolites associated with DIC could be gathered. Conclusion. We have established a breast cancer rat model in which DIC can be studied. Research in this model can aid in identifying mechanisms of DIC and testing novel interventions. Citation Format: Katherine Wallis, Marjan Boerma, Antino Allen, Joseph Su, Sam Makhoul, Ping-Ching Hsu. Establishment of a Breast Cancer Rat Model of Chemotherapy-Induced Cardiotoxicity [abstract]. In: Proceedings of the 2022 San Antonio Breast Cancer Symposium; 2022 Dec 6-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2023;83(5 Suppl):Abstract nr P3-08-08.

A Rat Model of Serous Borderline Ovarian Tumors Induced by 7,12-Dimethylbenz[a]anthracene

Optimization of 7,12-Dimethylbenz(a)anthracene-induced Rat Epithelial Ovarian Tumors.

Cross-species Comparison of Orthologous Gene Expression in Human Bladder Cancer and Carcinogen-Induced Rodent Models.

Enhanced Efficacy and Specificity of Epithelial Ovarian Carcinogenesis by Embedding A Dmba-Coated Cloth Strip in the Ovary of Rat

Establishment of Novel Rat Models for Premalignant Breast Disease.

Study of Rats' Mammary Precancer Models-Induced by DMBA Combined Estrogen and Progesterone

Multi-Modality Imaging-Monitored Creation of Rat Orthotopic Pancreatic Head Cancer with Obstructive Jaundice

Advances in understanding the molecular mechanisms of borderline ovarian tumors

Rats Models of Premalignant Breast Disease

Discovery of serum biomarkers implicated in the onset and progression of serous ovarian cancer in a rat model using iTRAQ technique

Role of MRI in Characterizing Serous Borderline Ovarian Tumor and Its Subtypes: Correlation of MRI Features with Clinicopathological Characteristics.

Evaluation of Ovarian Tumors with Multidetector Computed Tomography and Tumor Markers: Differentiation of Stage I Serous Borderline Tumors and Stage I Serous Malignant Tumors Presenting As Solid-Cystic Mass

A model for pancreatic cancer in SD rat and study on the relationship between expression of IL-8,MCP-1,MIP-1α mRNA and tumor-associated macrophage count

Establishment and Preliminary Observation of 7,12-Dimethylbenz[a]anthracene-induced Ovarian Tumor in Rabbits

Establishment of a Model for Pancreatic Cancer in Sprague-Dawely(SD) Rat and Study on the Relationship among IL-8,MCP-1,MIP-1α Mrna and MC Count in the Rat Pancreatic Cancer

Histopathological Alterations During Breast Carcinogenesis in a Rat Model Induced by 7,12-Dimethylbenz (a) Anthracene and Estrogen-Progestogen Combinations.

Abstract P3-08-08: Establishment of a Breast Cancer Rat Model of Chemotherapy-Induced Cardiotoxicity

Orthotopic Inflammation-Related Pancreatic Carcinogenesis in A Wild-Type Mouse Induced by Combined Application of Caerulein and Dimethylbenzanthracene

Expressions of Skp2 and P27 in Pancreatic Cancer and Non-cancerous Pancreatic Tissues of SD Rats

The selection of animal models influences the assessment of anti-tumor efficacy: promising sialic acid-conjugate modified liposomes demonstrate remarkable therapeutic effects in diverse mouse strains

Identification of Clinical and Molecular Features of Recurrent Serous Borderline Ovarian Tumour.